Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton, Dickinson and Co.

Shares of Becton Dickinson & Co. dropped 3.1% in morning trade Thursday, after the medical technology company topped fiscal second-quarter profit expectations, but slashed its full-year outlook, citing "recent regulatory and market pressures related to paclitaxel-coated devices.

Becton Dickinson's stock drops after profit, revenue growth outlook cut

Celgene

Schlumberger

The Zacks Research Daily presents the best research output of our analyst team.

Top Analyst Reports for Celgene, Schlumberger & Becton, Dickinson

Abbott Labs

Amgen

Quest Diagnostics

Gilead Sciences

While the overall stock market has been very strong year to date, with sectors like technology outperforming, the health care sector, which encompasses everything from pharmaceuticals to biotech to medical devices and more, has been absolutely wretched, lagging the S&P 500 by a huge 9%.

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Chevron

Lincoln Electric Hlds

National Retail Properties

if the analysts are correct, these are five dividend growth stocks that could produce capital gains in addition to their growing dividend payments.

Dividend Growth Stocks With Upside To Analyst Targets

Becton, Dickinson announces the FDA premarket approval for Venovo venous stent device.

Here's Why You Should Hold Becton, Dickinson Stock for Now

Per the recent press release issued by BD (BDX), it seems that the company still has immense confidence on the LUTONIX DCB.

BD Remains Confident About LUTONIX DCB Despite FDA Letter

Emerson Electric

Sysco

V.F.

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years.

Dividend Aristocrats With Capital Gains

Becton, Dickinson receives a number of regulatory approvals of late.

News for Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A Stock (BDXA)